Results of the citalopram to enhance cognition in Huntington disease trial-Reference-Cited by-同舟云学术

Results of the citalopram to enhance cognition in Huntington disease trial

Published:2013-12-27 Issue:3 Volume:29 Page:401-405
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Beglinger Leigh J.¹²,Adams William H.³,Langbehn Douglas¹,Fiedorowicz Jess G.¹,Jorge Ricardo¹,Biglan Kevin⁴,Caviness John⁵,Olson Blair¹,Robinson Robert G.¹,Kieburtz Karl⁴,Paulsen Jane S.¹

Affiliation:

1. Department of Psychiatry; University of Iowa; Iowa City Iowa USA

2. Neurological program; Elks Rehab Hospital; Boise Idaho USA

3. Division of Infectious Diseases; Loyola University Chicago; Chicago Illinois USA

4. Department of Neurology; University of Rochester, Rochester; New York USA

5. Department of Neurology; Mayo Clinic Scottsdale; Scottsdale Arizona USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference34 articles.

1. When does Huntington's disease begin?;Campodonico;J Int Neuropsychol Soc,1998

2. Evidence for specific cognitive deficits in preclinical Huntington's disease;Lawrence;Brain,1998

3. Clinical markers of early disease in persons near onset of Huntington's disease;Paulsen;Neurology,2001

4. Rate of functional decline in Huntington's disease;Marder;Huntington Study Group. Neurology,2000

5. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia;Lange;J Neurol Neurosurg Psychiatry,1995

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington’s disease;Brain Communications;2023-03-02

2. Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives;Journal of Personalized Medicine;2023-02-22

3. Emerging Stem Cell Therapy and Tissue Engineering-Based Approaches in Neurodegenerative Diseases;Handbook of Stem Cell Applications;2023

4. Different depression: motivational anhedonia governs antidepressant efficacy in Huntington’s disease;Brain Communications;2022-11-02

5. The effects of antidepressants on depressive symptoms in manifest Huntington's disease;Journal of Psychosomatic Research;2022-11